ConductScience.org, home

Comparison · NCT01638416-deaths

Arm B (Short Term Storage) vs Standard of Care (Long Term Storage): deaths from any cause

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Arm B (Short Term Storage) vs Standard of Care (Long Term Storage): deaths from any cause. Trial comparisons, record NCT01638416-deaths. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01638416-deaths

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.2850.2670.303wilson
Risk in group 20.2810.2630.299wilson
Risk difference, group 1 minus group 20.0042-0.02120.0296newcombe hybrid score
Risk ratio, group 1 over group 21.010.9281.11log
Odds ratio, group 1 over group 21.020.9011.16log
Number needed to harm, for one more death from any cause on Arm B (Short Term Storage) than on Standard of Care (Long Term Storage)238from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: standard of care.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Arm B (Short Term Storage)Blood Transfusion Freshest blood.~Blood transfusion: Blood transfusion in ICU patients aged 18 and over.6872,410EG000
Group 2Standard of Care (Long Term Storage)Blood Transfusion Standard of care- oldest blood.~Blood transfusion: Blood transfusion in ICU patients aged 18 and over.6782,414EG001

Harm

What it counts
Total, all-cause mortality
Time frame
Primary outcome was all-cause mortality measured up to day 90. Secondary outcomes included mortality / persistent organ dysfunction or death / days alive and free of mechanical ventilation / days alive and free of renal-replacement therapy measured all measured at day 28, new bloodstream infection measured during ICU stay, febrile nonhemolytic transfusion reactions during ICU stay, length of stay (hospital and ICU), and quality of life measured at day 180 after randomization.

Source ClinicalTrials.gov

Trial

Title
Standard Issue Transfusion Versus Fresher Red Blood Cell Use in Intensive Care- A Randomised Controlled Trial
NCT number
NCT01638416
Phases
PHASE3
Conditions
Transfusion, Age of Blood
Interventions
Blood transfusion
Lead sponsor
Australian and New Zealand Intensive Care Research Centre
Results first posted
2020-10-22

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT01638416-deaths